Mechanisms of relaxation by urocortin in renal arteries from male and female rats

British Journal of Pharmacology - Tập 140 Số 5 - Trang 1003-1007 - 2003
Elena Sanz1, Luis Monge1, Núria Fernández1, Belén Climent1, Godofredo Diéguez1, Ángel Luis Garcı́a-Villalón1
1Departamento de Fisiología, Facultad de Medicina, Universidad Autónoma, Madrid 28029, Spain.

Tóm tắt

Urocortin is a peptide recently identified, which is structurally related to the corticotropin‐releasing factor (CRF). To analyze the mechanisms that could be involved in its effect on renal arteries from male and female rats, the response to urocortin was studied in isolated segments, 2 mm long, of renal arteries from male and female rats. In renal artery segments precontracted with endothelin‐1 (1 nM), urocortin (1 pM–10 nM) produced concentration‐dependent relaxation, which was similar in the arteries from male and female rats. This relaxation was reduced by the antagonists of urocortin receptors astressin (1 μM) and α‐helical CRF(9–41) (1 μM) in arteries from both male and female rats. In renal arteries from female rats, the relaxation to urocortin was reduced by the inhibitor of adenyl cyclase SQ22536 (300 μM), by 8‐bromo‐cyclic‐ADP‐ribose (cADPR; 30 μM), an antagonist of the endogenous activator of sarcoplasmic Ca2+ channel cADPR and by ryanodine (1 μM), which produces depletion of sarcoplasmic Ca2+. In renal arteries from male rats, the relaxation to urocortin was increased by ryanodine, and was not modified by SQ22536 or 8‐bromo‐cADPR. These results suggest that the mechanisms involved in the relaxation to urocortin in renal arteries differ between female and male rats. In female rats, this relaxation may be mediated by the production of cyclic AMP (cAMP), synthesis of cADPR and release of sarcoplasmic Ca2+, whereas in male rats it is not mediated by cAMP. British Journal of Pharmacology (2003) 140, 1003–1007. doi:10.1038/sj.bjp.0705516

Từ khóa


Tài liệu tham khảo

10.3349/ymj.1995.36.3.232

10.1016/S0028-3908(98)00201-9

10.1016/S0014-2999(00)00618-X

10.1074/jbc.M204891200

10.1016/S0028-3908(01)00094-6

10.1126/science.1909457

10.1073/pnas.92.23.10575

10.1016/S0008-6363(02)00773-3

10.1038/sj.bjp.0704587

KISHIMOTO A., 1985, Studies on the phosphorylation of myelin basic protein by protenin kinase C and adenosine 3′ : 5′‐monophosphate‐dependent protein kinase, J. Biol. Chem., 260, 12492, 10.1016/S0021-9258(17)38898-1

10.1038/341152a0

10.1152/physrev.1997.77.4.1133

10.1016/S0021-9258(18)94230-4

10.1210/jc.83.12.4510

10.1038/sj.bjp.0704418

10.1016/0024-3205(93)90549-I

PARKES D.G., 2000, Urocortin: a novel player in cardiac control, News Physiol. Sci., 15, 264

10.1016/S0196-9781(01)00396-5

10.1152/ajpcell.1998.274.5.C1346

SADOSHIMA J., 1988, Cyclic AMP modulates Ca‐activated K channel in cultured smooth muscle cells of rat aortas, Am. J. Physiol., 255, H754

10.1016/S0008-6363(03)00293-1

10.1038/sj.bjp.0704670

10.1111/j.1476-5381.1996.tb15700.x

10.1038/sj.bjp.0702182

SCORNIK F.S., 1993, Modulation of coronary smooth muscle KCa channels by Gs alpha independent of phosphorylation by protein kinase A, Am. J. Physiol., 265, H1460

10.1016/S0014-2999(99)00506-3

SUTKO J.L., 1997, The pharmacology of ryanodine and related compounds, Pharmacol. Rev., 49, 53

10.1677/joe.0.1690177

10.1038/378287a0

WANG Z.W., 1996, Activation of KCa channels in airway smooth muscle cells by endogenous protein kinase A, Am. J. Physiol., 271, L100